Lazard Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Lazard Asset Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-75	Closed	-$3K	–	2416
2021 Q4	$3K	Buy	+75	New	+$4.5K	﹤0.01%	2200
2021 Q3	–	Sell	-1,531	Closed	-$128K	–	2212
2021 Q2	$128K	Buy	+1,531	New	+$101K	﹤0.01%	1289

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management's NBP Position: Q1 2022 in Review

Lazard Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 75 shares — an estimated $3K sold.

Lazard Asset Management first reported a position in NBP in Q2 2021 and held it in 2 quarters. The position peaked at $128K in Q2 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

Lazard Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Lazard Asset Management sold 75 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $3K.
Lazard Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 2 quarters.
Lazard Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $128K in Q2 2021.
120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Lazard Asset Management's 13F filing for Q1 2022, filed 13 May 2022.